DNA Damage Repair Defects as a Therapeutic Target in Pancreatic Cancer

In this downloadable slideset, Eileen M. O’Reilly, MD, reviews key data for PARP inhibition in pancreatic cancer

Eileen M. O'Reilly, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 13.4 MB
Released: January 17, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
AstraZeneca

Related Content

Tanios Bekaii-Saab, MD, FACP, on which patients are most likely to benefit from later-line checkpoint inhibitors for advanced gastric/GEJ cancers

Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP Released: July 18, 2019

Drs. Todd M. Bauer, Giuseppe Giaccone, Axel Grothey, John L. Marshall, and Michael J. Pishvaian discuss the latest data on 10 key clinical biomarkers in solid tumors.

John L. Marshall, MD
Program Director
Todd M. Bauer, MD Giuseppe Giaccone, MD, PhD Axel Grothey Headshot Axel Grothey, MD Michael J. Pishvaian, MD, PhD
Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: July 11, 2019 Expiration: July 10, 2020

Phase III TAGS: Subgroup analyses and QoL with trifluridine/tipiracil in previously treated metastatic gastric/GEJ cancer as reported by CCO from ASCO 2019

Released: June 11, 2019

Phase III POLO trial of maintenance therapy with olaparib in patients with metastatic pancreatic cancer and germline BRCA mutation as reported by CCO from ASCO 2019

Released: June 6, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?